HHS Drug Pricing Proposals: Some Things Are Off The Table

The US Centers for Medicare and Medicaid Services is proposing an interesting package of innovative pricing policy changes, but some of the topics not included might be as important as the ideas that are.

Medicare puzzle
CMS has decided that because Congress did not include changes to the protected classes policy in the IRA, that issue is settled. • Source: Shutterstock

The US Centers for Medicare and Medicaid Services will be pursuing an interesting and important package of drug pricing policy changes as it follows through on a White House executive order to expand the reforms incorporated in the 2022 Inflation Reduction Act.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Medicare

More from Government Payers